IP Library Granted Patent US 10,005,713
Granted Patent B2
US 10,005,713 · App. 14/975,333 · Granted Jun 26, 2018

Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position

Inventors: James Robertson Petrie (Goulburn, AU); Surinder Pal Singh (Downer, AU); Pushkar Shrestha (Lawson, AU); Jason Timothy McAllister (Portarlington, AU); Robert Charles De Feyter (Monash, AU); Malcolm David Devine (Vernon, CA); Xue-Rong Zhou (Harrison, AU)
Assignees: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION; GRAINS RESEARCH AND DEVELOPMENT CORPORATION; NUSEED PTY LTD.
C07C69/587A01H5/00A23D9/00A61K31/20A61K31/201A61K31/202A61K31/23A61K31/232A61K36/185A61K36/31C11B1/10C11B3/02C11B3/04C11B3/10C11B3/12C11B7/0075C11C3/003C12N15/52C12N15/8247A61K2236/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,005,713
App. No.
14/975,333
Granted
Jun 26, 2018
Kind
B2
Abstract

The present invention relates to lipid comprising docosapentaenoic acid and/or docosahexaenoic acid preferentially esterified at the sn-2 position of triacylglycerol, and processes for producing and using the lipid.

Claims (59)

1. Extracted plant lipid comprising a total fatty acid content which comprises fatty acids in an esterified form, the fatty acids comprising palmitic acid and C22 polyunsaturated fatty acid which comprises docosapentaenoic acid (DPA) and/or docosahexaenoic acid (DHA), and the fatty acids optionally comprising myristic acid (C14:0), wherein at least 35% of the DPA and/or DHA esterified in triacylglycerol (TAG) in the extracted plant lipid is esterified at the sn-2 position of the TAG, wherein a level of palmitic acid between 2% and 16% is present in the total fatty acid content of the extracted plant lipid, and wherein myristic acid, if present, is present at a level of less than 1% of the total fatty acid content of the extracted plant lipid.

2. The extracted plant lipid of claim 1 which has one or more of the following features

i) the fatty acids further comprise one or more or all of oleic acid, ω6 fatty acids which comprise linoleic acid (LA), ω3 fatty acids which comprise α-linolenic acid (ALA) and optionally one or more or all of stearidonic acid (SDA), eicosapentaenoic acid (EPA), and eicosatetraenoic acid (ETA),

ii) at least 40% of the DPA and/or DHA esterified in TAG in the extracted plant lipid is esterified at the sn-2 position of the TAG,

iii) the extracted plant lipid comprises a TAG content of at least 90% by weight of the extracted plant lipid, and

iv) a level of DPA and/or DHA of between 1% and 35% is present in the total fatty acid content of the extracted plant lipid.

3. The extracted plant lipid of claim 2 , wherein the level of DPA and/or DHA in the total fatty acid content of the extracted plant lipid is between 7% and 28%.

4. The extracted plant lipid of claim 1 which has one or more of the following features

i) the level of palmitic acid in the total fatty acid content of the extracted plant lipid is between 2% and 15%,

ii) the level of myristic acid (C14:0) in the total fatty acid content of the extracted plant lipid is about 0.1%,

iii) a level of oleic acid between 1% and 60% is present in the total fatty acid content of the extracted plant lipid,

iv) a level of linoleic acid (LA) between 4% and 35% is present in the total fatty acid content of the extracted plant lipid,

v) a level of α-linolenic acid (ALA) between 4% and 40% is present in the total fatty acid content of the extracted plant lipid,

vi) a level of γ-linolenic acid (GLA) of less than 4% is present in the total fatty acid content of the extracted plant lipid,

vii) a level of stearidonic acid (SDA) of less than 10% is present in the total fatty acid content of the extracted plant lipid,

viii) a level of eicosatetraenoic acid (ETA) of less than 6% is present in the total fatty acid content of the extracted plant lipid,

ix) a level of eicosatrienoic acid (ETrA) of less than 4% is present in the total fatty acid content of the extracted plant lipid,

x) a level of eicosapentaenoic acid (EPA) of between 4% and 15% is present in the total fatty acid content of the extracted plant lipid,

xi) the extracted plant lipid comprises less than 0.1% of ω6-docosapentaenoic acid (22:5 Δ4,7,10,13,16 ) in its total fatty acid content,

xii) the total fatty acid content of the extracted plant lipid comprises a total saturated fatty acid content whose level is between 4% and 25% of the total fatty acid content,

xiii) the total fatty acid content of the extracted plant lipid comprises a total monounsaturated fatty acid content whose level is between 4% and 40% of the total fatty acid content,

xiv) the total fatty acid content of the extracted plant lipid comprises a total polyunsaturated fatty acid content whose level is between 20% and 75% of the total fatty acid content of the extracted plant lipid,

xv) the total fatty acid content of the extracted plant lipid comprises a total ω6 fatty acid content whose level is between 35% and 50% of the total fatty acid content,

xvi) the total fatty acid content of the extracted plant lipid comprises a new ω6 fatty acid content whose level is less than 10% of the total fatty acid content,

xvii) the total fatty acid content of the extracted plant lipid comprises a total ω3 fatty acid content whose level is between 36% and 65% of the total fatty acid content,

xviii) the total fatty acid content of the extracted plant lipid comprises a total new ω3 fatty acid content whose level is between 21% and 45% of the total fatty acid content,

xix) the total fatty acid content of the extracted plant lipid comprises a ratio of total ω6 fatty acids: total ω3 fatty acids of between 0.1 and 1,

xx) the total fatty acid content of the extracted plant lipid comprises a ratio of new ω6 fatty acids: new ω3 fatty acids of between 0.02 and 1,

xxi) the total fatty acid content of the extracted plant lipid comprises a fatty acid composition which is based on an efficiency of conversion of ALA to DPA and/or DHA of between 22% and 70%,

xxii) the total fatty acid content of the extracted plant lipid has a C20:1 content of less than 1.5%,

xxiii) the extracted plant lipid comprises diacylglycerol (DAG), which DAG comprises DPA and/or DHA,

xxiv) the extracted plant lipid comprises less than 5% non-esterified fatty acids and/or phospholipid,

xxv) the most abundant DHA-containing TAG species in the lipid is DHA/18:3/18:3 (TAG 56:12), and

xxvi) the lipid comprises tri-DHA TAG (TAG 66:18).

5. A process for producing extracted plant lipid, comprising the steps of

i) obtaining a transgenic plant part or plurality of transgenic plant parts comprising lipid, the lipid comprising a total fatty acid content which comprises fatty acids in an esterified form, the fatty acids comprising palmitic acid and C22 polyunsaturated fatty acid which comprises docosapentaenoic acid (DPA) and/or docosahexaenoic acid (DHA), and the fatty acids optionally comprising myristic acid (C14:0), and

ii) extracting lipid from the transgenic plant part or plurality of transgenic plant parts, wherein at least 35% of the DPA and/or DHA esterified in triacylglycerol (TAG) in the extracted plant lipid is esterified at the sn-2 position of the TAG, wherein a level of palmitic acid between 2% and 16% is present in the total fatty acid content of the extracted plant lipid, and wherein myristic acid, if present, is present at a level of less than 1% of the total fatty acid content of the extracted plant lipid.

6. The process of claim 5 , wherein the extracted plant lipid has one or more of the following features

i) the fatty acids further comprise one or more or all of oleic acid, ω6 fatty acids which comprise linoleic acid (LA), ω3 fatty acids which comprise α-linolenic acid (ALA) and optionally one or more of stearidonic acid (SDA), eicosapentaenoic acid (EPA), and eicosatetraenoic acid (ETA),

ii) at least 40% of the DPA and/or DHA esterified in TAG in the extracted plant lipid is esterified at the sn-2 position of the TAG,

iii) the extracted plant lipid comprises a TAG content of at least 90%, and

iv) a level of DPA and/or DHA between 1% and 35% is present in the total fatty acid content of the extracted plant lipid.

7. The process of claim 5 , wherein the transgenic plant part has one or more or all of the following features

i) an efficiency of conversion of oleic acid to DPA and/or DHA in the plant part which is between 10% and 50%,

ii) an efficiency of conversion of LA to DPA and/or DHA in the plant part which is between 15% and 50%, and

iii) an efficiency of conversion of ALA to DPA and/or DHA in the plant part which is between 17% and 55%.

8. The process of claim 5 , wherein the total oil content of the transgenic plant part is between 50% and 100% of the total oil content of a corresponding wild-type plant part.

9. The process of claim 5 which further comprises treating the extracted plant lipid to increase the level of DPA and/or DHA as a percentage of the total fatty acid content, wherein the treatment comprises one or more of fractionation, distillation or transesterification.

10. The process of claim 9 which comprises the production of methyl- or ethyl-esters of DPA and/or DHA.

11. A method of treating an extracted plant lipid to increase its level of DPA and/or DHA as a percentage of its total fatty acid content, the method comprising one or more of fractionating, distillating or transesterifying extracted plant lipid comprising fatty acids in an esterified form, the fatty acids comprising palmitic acid and C22 polyunsaturated fatty acid which comprises docosapentaenoic acid (DPA) and/or docosahexaenoic acid (DHA), and the fatty acids optionally comprising myristic acid (C14:0), wherein at least 35% of the DPA and/or DHA esterified in triacylglycerol (TAG) is esterified at the sn-2 position of the TAG, wherein a level of palmitic acid between 2% and 16% is present in the total fatty acid content of the extracted plant lipid, and wherein myristic acid, if present, is present at a level of less than 1% of the total fatty acid content of the extracted plant lipid.

12. The process of claim 11 which comprises the production of methyl- or ethyl-esters of DPA and/or DHA.

13. The extracted plant lipid of claim 1 , wherein between 35% and 50% of the DPA and/or DHA esterified in the TAG is esterified at the sn-2 position of the TAG.

14. The extracted plant lipid of claim 1 , wherein DPA is present at a level of between 1% and 35% of the total fatty acid content.

15. The extracted plant lipid of claim 1 , wherein DHA is present at a level of between 1% and 35% of the total fatty acid content.

16. The process of claim 5 , wherein between 35% and 50% of the DPA and/or DHA esterified in the TAG is esterified at the sn-2 position of the TAG.

17. The process of claim 16 , wherein DPA is present at a level of between 1% and 35% of the total fatty acid content.

18. The process of claim 16 , wherein DHA is present at a level of between 1% and 35% of the total fatty acid content.

19. The process of claim 11 , wherein between 35% and 50% of the DPA and/or DHA esterified in the TAG is esterified at the sn-2 position of the TAG.

20. The process of claim 19 , wherein DHA is present at a level of between 1% and 35% of the total fatty acid content.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2021
From: NUSEED PROPRIETARY LIMITED
To: NUSEED NUTRITIONAL AUSTRALIA PTY LTD
Reel/Frame 057019/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2018
From: MCALLISTER, JASON TIMOTHY
To: NUSEED PTY LTD.
Reel/Frame 045163/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2018
From: DEVINE, MALCOLM DAVID
To: CROOKEDHOLM PARTNERS INC.
Reel/Frame 045163/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2018
From: PETRIE, JAMES ROBERTSON; SINGH, SURINDER PAL; SHRESTHA, PUSHKAR; DE FEYTER, ROBERT CHARLES; ZHOU, XUE-RONG
To: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Reel/Frame 045163/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2018
From: NUFARM AGRICULTURE INC.
To: NUSEED PTY LTD.
Reel/Frame 045163/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2018
From: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
To: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION; GRAINS RESEARCH AND DEVELOPMENT CORPORATION; NUSEED PTY LTD.
Reel/Frame 045163/0354 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2018
From: CROOKEDHOLM PARTNERS INC.
To: NUFARM AGRICULTURE INC.
Reel/Frame 045163/0328 →
Priority Claims (1)
AR 20140104761 · Dec 18, 2014 · national
Continuity (5)
Continuation In Part PCTAU2015050340 · Jun 18, 2015
Continuation In Part 14743531 · Jun 18, 2015
Continuation In Part PCTAU2014050433 · Dec 18, 2014
Continuation In Part 14575756 · Dec 18, 2014
Related Publication 20160177220A1 · Jun 23, 2016
Cited By (3)
US 12,195,739 US 12,203,087 US 12,281,317